Korenberg Matthew E bought PVLA
June 12, 2026 · Form 4 insider transaction
Korenberg Matthew E bought 1,000 shares of Palvella Therapeutics, Inc. at $13.60 per share, a transaction worth $13.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$13.60
Total value
$13.6K
InsiderKorenberg Matthew E
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 12, 2026
Filing dateJune 16, 2026
Shares owned after1,000
OwnershipDirect
10b5-1 planNo
AmendedNo